JOHN PATIENCE - 31 Mar 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director, Chairman
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for John Patience
Issuer symbol
BDSX
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
4
Filing time
02 Apr 2025, 16:25:49 UTC
Previous filing
03 Dec 2024
Next filing
22 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +46,686 +14% 384,612 31 Mar 2025 Direct F1
holding BDSX Common Stock 2,153,298 31 Mar 2025 By Patience Enterprises LP F2
holding BDSX Common Stock 4,829,611 31 Mar 2025 By John Patience Living Trust dated 7/23/1993 F3
holding BDSX Common Stock 52,988 31 Mar 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -46,686 -100% $0.000000 0 31 Mar 2025 Common Stock 46,686 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
F4 These RSUs vested in full on March 31, 2025, and had no expiration date.